BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 744578)

  • 1. Glucagon responses to secretion and CCK-PZ in diabetes and chronic pancreatitis.
    Kalk WJ; Vinik AI; Jackson WP
    Horm Metab Res; 1978 Nov; 10(6):562. PubMed ID: 744578
    [No Abstract]   [Full Text] [Related]  

  • 2. Insulin responses to crude cholecystokinin-pancreozymin in normal subjects, in patients with chronic pancreatitis and patients with mild maturity onset diabetes.
    Kalk WJ; Vinik AI; Botha JL; Keller P; Jackson WP
    J Clin Endocrinol Metab; 1975 Jul; 41(1):172-6. PubMed ID: 1150859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated plasma levels of glucagon-like peptide-1 after oral glucose ingestion in patients with pancreatic diabetes.
    Hiroyoshi M; Tateishi K; Yasunami Y; Maeshiro K; Ono J; Matsuoka Y; Ikeda S
    Am J Gastroenterol; 1999 Apr; 94(4):976-81. PubMed ID: 10201468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Diabetes mellitus in patients with chronic alcoholic pancreatitis].
    Sadokov VM; Vinokurova LV
    Ter Arkh; 1993; 65(10):27-9. PubMed ID: 8296228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of alanine-stimulated glucagon secretion by secretin in the dog.
    Santeusanio F; Faloona GR; Unger RH
    Horm Metab Res; 1973 Nov; 5(6):425-7. PubMed ID: 4766996
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of the gastrointestinal hormones, secretin and cholecystokinin-pancreozymin, on insulin and glucagon release in healthy and diabetic subjects.
    Raptis S; Schröder KE; Rothenbuchner G; Pfeiffer EF
    Isr J Med Sci; 1972 Jun; 8(6):769. PubMed ID: 4559420
    [No Abstract]   [Full Text] [Related]  

  • 7. Inhibition of gastric secretion by combined secretin and CCK and combined glucagon and CCK.
    Hendel L; Henriksen FW
    Scand J Gastroenterol Suppl; 1976; 42():37-9. PubMed ID: 1070793
    [No Abstract]   [Full Text] [Related]  

  • 8. [Diabetes mellitus in acute and chronic pancreatitis (author's transl)].
    Strohmeyer G; Gottesbüren H; Behr C
    Dtsch Med Wochenschr; 1974 Jul; 99(28):1481-8. PubMed ID: 4605614
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effect of secretin intramuscularly injected on pancreatic polypeptide, insulin and glucagon in diabetic patients (author's transl)].
    Toyota T; Koizumi K; Kai K; Umezu M; Miura M
    Horumon To Rinsho; 1979; 27(12):1395-8. PubMed ID: 397015
    [No Abstract]   [Full Text] [Related]  

  • 10. Recent research developments in diabetes mellitus. IV.
    Sharkey TP
    J Am Diet Assoc; 1968 Feb; 52(2):108-17. PubMed ID: 4866012
    [No Abstract]   [Full Text] [Related]  

  • 11. Plasma glucagon response to blood glucose fall, gastrointestinal hormones and arginine in man.
    Oneda A; Sato M; Matsuda K; Yanbe A; Maruhama Y
    Tohoku J Exp Med; 1972 Jul; 107(3):241-51. PubMed ID: 4639665
    [No Abstract]   [Full Text] [Related]  

  • 12. Chronic pancreatitis and diabetes mellitus: plasma and gastroduodenal mucosal profiles of regulatory peptides (gastrin, motilin, secretin, cholecystokinin, gastric inhibitory polypeptide, somatostatin, VIP, substance P, pancreatic polypeptide, glucagon, enteroglucagon, neurotensin).
    Domschke S; Bloom SR; Adrian TE; Lux G; Domschke W
    Hepatogastroenterology; 1988 Oct; 35(5):229-37. PubMed ID: 2465985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diabetes mellitus secondary to chronic pancreatitis.
    Larsen S
    Dan Med Bull; 1993 Apr; 40(2):153-62. PubMed ID: 8495594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical studies of gastrointestinal hormones and pancreatic function].
    Ohara H
    Horumon To Rinsho; 1976; 24(2):113-20. PubMed ID: 943245
    [No Abstract]   [Full Text] [Related]  

  • 15. Secretion of labelled proteins by the isolated dog pancreas in the response to secretin and cholecystokinin.
    Laval J; Frexinos J; Laval JP; Ribet A
    Biomedicine; 1977 Feb; 26(1):65-70. PubMed ID: 861347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of accuracy of plasma alpha-amino nitrogen profiles as an indicator of exocrine pancreatic function both after continuous and bolus stimulation of the pancreas with secretin and cholecystokinin-pancreozymin.
    Lembcke B; Konle O; Duan LP; Caspary WF
    Z Gastroenterol; 1994 Dec; 32(12):679-83. PubMed ID: 7871858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of different endocrine stimulation tests in nondiabetic patients with chronic pancreatitis.
    von Tirpitz C; Glasbrenner B; Mayer D; Malfertheiner P; Adler G
    Hepatogastroenterology; 1998; 45(22):1111-6. PubMed ID: 9756016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Plasma insulin in chronic pancreatitis].
    Azerad E; Bernier JJ; Lubetzki J; Duprey J; Friedler D; Croisier JC
    Diabete; 1967; 15(4):269-74. PubMed ID: 5634172
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of glucagon on pure human exocrine pancretic secretion.
    Fontana G; Costa PL; Tessari R; Labo G
    Am J Gastroenterol; 1975 Jun; 63(6):490-4. PubMed ID: 1146806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The indices of pancreatic incretory activity in patients with chronic pancreatitis and disordered carbohydrate metabolism].
    Geller LI; Pashko MM; Obukhova GG
    Vrach Delo; 1990 Nov; (11):77-9. PubMed ID: 2098992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.